April 05, 2019
Unknown to most people, the science of aging has made enormous progress in the last few years. Human clinical trials have already been completed for a new anti-aging substance called Nicotinamide Riboside and it has demonstrated some promising results.
To understand how Nicotinamide Riboside works, let’s talk about NAD+ first. Your cells are composed of millions of parts with complex structures. All these parts need to constantly be broken down, cleaned up, and rebuilt. As we start to age, this process becomes less efficient and, consequently, parts of the cell start to break down or aren’t produced in quantities that we need. One of these parts is called NAD+, a coenzyme that tells our bodies to look after themselves.
By age 50, we only have about half as much NAD+ in our bodies as we did when we were 20. Low amounts of NAD+ are associated with a host of diseases from skin cancer to Alzheimer’s to cardiovascular disease. But since NAD+ is too big to enter the cell, we can’t just take NAD+.
Scientists then discovered a more flexible substance that could enter the cell and turn on NAD+ production inside. That substance is called Nicotinamide Riboside.
In 2016, multiple clinical trials
showed that Nicotinamide Riboside boosted the multiplication of skin, brain, and muscle stem cells. They also had a higher ability to repair their DNA and had slightly increased lifespans. Even NASA got interested in Nicotinamide Riboside
, as they were trying to look for a way to minimize DNA damage astronauts incurred from cosmic rays during long-distance space travel.
Nicotinamide Riboside is a serious candidate for the first human anti-aging pill. Here at Nooflux Labs, we have developed our first anti-aging supplement that contains the same amount of Nicotinamide Riboside used in these human clinical trials. We will be launching our product soon, so keep a lookout for more updates.
Leave a comment
Comments will be approved before showing up.